Islam Hamad
Publications by Year
Research Areas
Nanoparticle-Based Drug Delivery, Complement system in diseases, Advanced Drug Delivery Systems, Nanoplatforms for cancer theranostics, Platelet Disorders and Treatments
Most-Cited Works
- → Synthesis, Characterization, and Applications of Metal Nanoparticles(2019)301 cited
- → Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere−Serum Interface: Implications for Stealth Nanoparticle Engineering(2010)272 cited
- → Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process(2008)251 cited
- → Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production(2006)200 cited
- → Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: The challenges ahead(2010)165 cited
- → Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover(2008)119 cited
- → Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin(2016)83 cited
- → Liposome-Mediated Triggering of Complement Cascade(2008)82 cited
- → Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article(2020)79 cited
- → Activation of the Human Complement System by Cholesterol-Rich and PEGylated Liposomes—Modulation of Cholesterol-Rich Liposome-Mediated Complement Activation by Elevated Serum LDL and HDL Levels(2006)75 cited